If You Can't Beat 'Em … Hire 'Em? PhRMA Exec Is New GPhA CEO
This article was originally published in The Pink Sheet Daily
Chip Davis still believes in innovation, but now must balance that with affordability in new role leading the generic association.
You may also be interested in...
Association for Accessible Medicines’ interim leader is General Counsel Jeffrey Francer; Chip Davis’ four-and-half year tenure included a total rebrand of the association, a significant legislative victory with the CREATES act – and an abrupt departure for the Healthcare Distribution Alliance.
A scientist may provide a certain look, but understanding politics is more important to ensuring the health of the pharma industry, the outgoing president and CEO of BIO said in an interview.
Long-time CEO of the Biotechnology Innovation Organization will remain until after the 2020 election and help with the leadership transition.